Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GR2001 injection vs HTIG for tetanus post-exposure prophylaxis
CTR20243076Phase 3Completed
- Sponsor
- Zhixiang Jintai
- Start
- Sep 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of vecantoxatug in Tetanus, sponsored by Zhixiang Jintai. Started Sep 2024; status: completed.
02
Drugs
vecantoxatug
03
Conditions
Tetanus
Beyond the preview
Go deeper on CTR20243076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243076.